VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MHUA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MHUAMeihua International Medical Technologies Co., Ltd.
$7.61$2M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMHUACash Flow

Meihua International Medical Technologies Co., Ltd. (MHUA) Cash Flow Statement

7Y historyFree accessUpdated daily

Free cash flow volatility is pronounced, with a negative 26.1% FCF margin in 2025Q2 driven by a $9.9M outflow in working capital.

MHUA Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Cash from Operations2.53M14.64M2.28M-9.16M-54.66K5.33M9.31M11.82M
Operating CF Margin %-15.1%2.34%-8.87%-0.05%5.98%11.69%15.61%
Operating CF Growth %-1189.6%543.16%124.84%-16662.78%-101.03%-42.78%-21.23%-
Net Income18.55M10.84M11.59M6.18M19.99M19.05M15.43M15.48M
Depreciation & Amortization1.02M571.03K470.99K563.46K622.47K523.43K509.22K567.77K
Stock-Based Compensation00000000
Deferred Taxes0-642.63K-370.48K00000
Other Non-Cash Items-5.99M3.9M2.18M4.51M15.28K2.85K-9.53K6.71M
Working Capital Changes-11.05M-27.97K-11.6M-20.41M-20.68M-14.25M-6.62M-10.94M
Change in Receivables-13.91M-3.21M-14.02M-7.12M-20.07M-13.64M-4.71M-11.09M
Change in Inventory575.72K165.76K-528.63K35.03K105.12K-219.79K802.61K-170.6K
Change in Payables0932.49K185.9K-3.37M4.91M5.34M-4.23M0
Cash from Investing-16.84M-20.42M-12.46M-8.62M-833.82K-16.09M-8.9M-7.57M
Capital Expenditures-324.57K-133.55K-1.18M-2.7M-850.23K-16.12M-8.95M-12.3K
CapEx % of Revenue0.18%0.14%1.22%2.61%0.82%18.1%11.24%0.02%
Acquisitions0-89.72K0658.46K16.41K25.2K50.6K0
Investments--------
Other Investing-16.51M-15.9M-11.63M23.15K000-7.56M
Cash from Financing12.82M6.21M706.13K37.25M1.86M1.71M923.77K-4.2M
Debt Issued (Net)6.62M6.41M706.13K2.08M1.86M434.52K579.03K0
Equity Issued (Net)-200K-200K01000K01000K00
Dividends Paid00000000
Share Repurchases-200K-200K000000
Other Financing6.4M00635.31K00344.74K-4.2M
Net Change in Cash-71.78K362.07K-9.81M18.59M961.94K-8.84M1.23M-794.34K
Free Cash Flow12.11M14.5M-2.41M-11.86M-904.89K-10.79M356.12K11.8M
FCF Margin %6.59%14.97%-2.48%-11.48%-0.87%-12.12%0.45%15.59%
FCF Growth %157.8%701.59%79.68%-1210.85%91.62%-3130.93%-96.98%-
FCF per Share37.9652.99-10.07-50.67-3.83-44.711.4859.02
FCF Conversion (FCF/Net Income)0.65x1.35x0.20x-1.47x-0.00x0.28x0.60x0.76x
Interest Paid129.86K247.62K250.78K194.67K180.74K137.16K97.79K0
Taxes Paid03.66M3.58M5.7M5.04M4.36M3.9M0

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetHealthy
Cash FlowDeteriorating
Top Statement Risk

Working Capital Liquidity Risk

Earnings Quality Decoupled From Cash

According to recent financial disclosures, MHUA's operating cash flow to net income ratio reached a concerning -6.30 in 2025Q2, highlighting a severe disconnect between reported accounting profits and the actual cash generated from core operations during the most recent quarterly reporting period.

The persistent inability to convert net income into operating cash flow suggests that the company's earnings quality is significantly compromised by non-cash accruals or delayed collections. Investors should monitor whether this divergence reflects structural issues in revenue recognition or simply an aggressive buildup of receivables that may never materialize as cash.

Free Cash Flow Volatility Persists

As reported in the company's cash flow statements, MHUA's free cash flow margin plummeted to -26.1% in 2025Q2, marking a sharp reversal from the positive 26.2% margin achieved in 2024Q4 and underscoring the extreme instability inherent in the firm's current cash generation profile.

The erratic nature of free cash flow suggests that the business model is highly sensitive to working capital swings rather than consistent operational performance. This volatility makes it difficult to rely on internal cash generation to fund future growth or maintain the current dividend policy, if any.

Working Capital Dragging Cash Flow

Based on the provided quarterly data, MHUA experienced a massive working capital outflow of $9.9M in 2025Q2, which directly mirrors the negative operating cash flow and indicates that the company is struggling to manage its cash conversion cycle effectively in the current environment.

The recurring negative working capital changes suggest that the company is effectively financing its customers' operations through extended payment terms. This trend warrants further investigation into the credit quality of the hospital systems MHUA serves and the potential for future write-downs of aged accounts receivable.

Cumulative Earnings Mask Cash Reality

Data from the last ten quarters reveals a consistent pattern where net income frequently exceeds operating cash flow, with the cumulative gap suggesting that reported profitability may be significantly overstated relative to the actual cash liquidity available to the firm's balance sheet over time.

This long-term divergence implies that the company's growth has been largely funded by accounting accruals rather than organic cash generation. Analysts should be wary of this trend, as it often precedes a period of liquidity stress when the underlying receivables eventually fail to convert into cash.

MHUA — Frequently Asked Questions

Quick answers to the most common questions about buying MHUA stock.

How much cash does Meihua International Medical Technologies Co., Ltd. (MHUA) generate from operations?

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $14.6M in net cash from operating activities in 2024. This reflects the cash generated directly from core business operations.

What is Meihua International Medical Technologies Co., Ltd.'s free cash flow?

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $14.5M in free cash flow in 2024. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Meihua International Medical Technologies Co., Ltd.'s capital expenditure (CapEx)?

Meihua International Medical Technologies Co., Ltd. (MHUA) spent $0.1M on capital expenditures in 2024. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Meihua International Medical Technologies Co., Ltd. distribute cash to shareholders?

In 2024, Meihua International Medical Technologies Co., Ltd. (MHUA) spent $0.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.